O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Year: 2005
Type: conference-abstract
Source: Lung Cancer
Authors: G. Blumenschein, C. Ludwig, G. Thomas, E. Tan, M. Fanucchi, A. Santoro, J. Crawford, J. Breton, M. O'Brien, F. Khuri
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2095542597